Dr Michelle Sullivan was appointed to the Trust Board in 2021.
Michelle is General Manager of Cancer Research Trust NZ and CEO of NeuroEndocrine Cancer New Zealand, New Zealand’s national charity supporting neuroendocrine cancer patients. She is the former Board Chair at Middlemore Clinical Trials, founding CEO of the advocacy alliance New Zealanders for Health Research, and the former CEO at NZBIO, New Zealand's Bioscience Industry Association.
Michelle is also the founder and director of bioscience consulting firm Electric Sheep Ltd and has undertaken a range of diverse consulting projects within the public and private sectors. Prior to appointment to the Trust Board, Michelle chaired the Strategic Alliance board for the Malaghan Institute’s CAR T-cell cancer immunotherapy partnership.
Michelle holds a PhD in protein biochemistry from Massey University and an Honours degree in Biochemistry from the University of Otago.
BSc (Hons) Otago, PhD (Massey)